Wells Fargo
TRIB

Wells Fargo’s Trinity Biotech TRIB Stock Holding History

Wells Fargo’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.36K Buy
+83
New +$1.83K ﹤0.01% 6300
2022
Q2 		– Sell
-6
Closed -$1K – 7501
2022
Q1 		$1K Hold
6
– – ﹤0.01% 6868
2021
Q4 		$1K Hold
6
– – ﹤0.01% 7079
2021
Q3 		$2K Hold
6
– – ﹤0.01% 6596
2021
Q2 		$2K Hold
6
– – ﹤0.01% 6565
2021
Q1 		$3K Hold
6
– – ﹤0.01% 6599
2020
Q4 		$3K Hold
6
– – ﹤0.01% 6241
2020
Q3 		$2K Hold
6
– – ﹤0.01% 6149
2020
Q2 		$2K Hold
6
– – ﹤0.01% 6114
2020
Q1 		$1K Hold
6
– – ﹤0.01% 6087
2019
Q4 		$1K Hold
6
– – ﹤0.01% 6274
2019
Q3 		$1K Buy
+6
New +$1.56K ﹤0.01% 6299
2017
Q3 		– Sell
-1
Closed – – 6469
2017
Q2 		$0 Hold
1
– – ﹤0.01% 6453
2017
Q1 		$0 Hold
1
– – ﹤0.01% 6502
2016
Q4 		$1K Hold
1
– – ﹤0.01% 6180
2016
Q3 		$1K Sell
1
-59
-98% -$110K ﹤0.01% 6123
2016
Q2 		$102K Sell
60
-5
-8% -$8.45K ﹤0.01% 4822
2016
Q1 		$114K Sell
65
-6
-8% -$9.55K ﹤0.01% 4745
2015
Q4 		$125K Sell
71
-137
-66% -$243K ﹤0.01% 4759
2015
Q3 		$357K Sell
208
-5
-2% -$12.1K ﹤0.01% 4158
2015
Q2 		$578K Buy
213
+17
+9% +$44.2K ﹤0.01% 3987
2015
Q1 		$567K Buy
196
+11
+6% +$30.5K ﹤0.01% 3868
2014
Q4 		$484K Sell
185
-30
-14% -$77.6K ﹤0.01% 3967
2014
Q3 		$588K Sell
215
-89
-29% -$289K ﹤0.01% 3799
2014
Q2 		$1.05M Buy
304
+53
+21% +$188K ﹤0.01% 3483
2014
Q1 		$913K Buy
251
+5
+2% +$19.7K ﹤0.01% 3562
2013
Q4 		$928K Buy
246
+14
+6% +$50.4K ﹤0.01% 3461
2013
Q3 		$757K Buy
232
+46
+25% +$135K ﹤0.01% 3522
2013
Q2 		$470K Buy
+186
New +$463K ﹤0.01% 3720

Other funds holding TRIB

HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
YAG
Yorkville Advisors Global Mountainside, New Jersey $155M AUM 58.46% 1-Year Est. Return
WN
Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo's TRIB Position: Q1 2026 in Review

Wells Fargo opened a new position in Trinity Biotech (TRIB) in Q1 2026: 83 shares worth $1.36K. The stake represents ﹤0.01% of the portfolio and ranks #6300 among its holdings. This is a return to the name: Wells Fargo previously reported a position in TRIB as recently as Q1 2022.

Wells Fargo first reported a position in TRIB in Q2 2013 and has held it in 29 quarters since. The position peaked at $1.05M in Q2 2014. 21 funds tracked by Wall St. Rank hold TRIB as of Q1 2026.

  • Wells Fargo held 83 shares of Trinity Biotech worth $1.36K as of Q1 2026.
  • Trinity Biotech was a new Wells Fargo position in Q1 2026.
  • Trinity Biotech made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6300 holding.
  • Wells Fargo first reported a position in Trinity Biotech in Q2 2013 and has held it in 29 quarters since.
  • Wells Fargo's Trinity Biotech position peaked at $1.05M in Q2 2014.
  • 21 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.